Literature DB >> 25528316

Acceptance and psychological impact of implantable defibrillators amongst adults with congenital heart disease.

Radwa Bedair1, Sonya V Babu-Narayan2, Konstantinos Dimopoulos2, Sadia Quyam1, Anne-Marie Doyle1, Lorna Swan3, Michael A Gatzoulis2, Tom Wong4.   

Abstract

BACKGROUND: The psychological impact of implantable cardioverter defibrillators (ICDs) in adults with congenital heart disease (ACHD) has not been established.
OBJECTIVE: To compare device acceptance, quality of life, anxiety and depression between ACHD patients with ICDs (ICD-Congenital), with pacemakers (PPM-Congenital), with no devices (No Device-Congenital) and non-ACHD patients with ICDs (ICD-Non-Congenital).
METHODS: A total of 147 ACHD and 46 non-ACHD patients (age 45.0±14.7 years, 56.5% males) completed the Florida Patient Acceptance Survey (FPAS), the 36-item Short Form Health Survey (SF-36) and Hospital Anxiety & Depression Scale (HADS).
RESULTS: ICD-Congenital patients (n=59) showed lower device acceptance compared to PPM-Congenital patients (n=41), p=0.04, and reported worse quality of life (p=0.001) and higher prevalence of depression (p=0.009) when compared to No Device-Congenital (n=47) patients. ICD-Congenital and ICD-Non-Congenital patients (n=46) showed similar mental and physical health, device acceptance, anxiety and depression. Within ICD-Congenital, patients with poorest device acceptance (FPAS <67, "Non-Acceptors") showed significantly lower mental health scores (p=0.008), and higher levels of anxiety (p=0.02) and depression (p=0.01) compared to "Acceptors" (FPAS ≥67). "Non-Acceptors" were younger at survey (p=0.006), younger at ICD implantation (p=0.01) and were less likely to have received appropriate shocks (p=0.03).
CONCLUSION: Younger age and lack of appropriate ICD shocks are risk factors for poor ICD acceptance. Device acceptance is lower in adults with congenital heart disease who receive an ICD than those who receive pacemakers. Appropriate screening for anxiety and depression may be warranted for ACHD patients considered for ICD implantation or already living with ICDs.
Copyright © 2014 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Adult congenital heart disease; Anxiety; Depression; Device acceptance; Implantable cardioverter defibrillator; Quality of life

Mesh:

Year:  2014        PMID: 25528316     DOI: 10.1016/j.ijcard.2014.12.028

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  10 in total

Review 1.  Current research status on the psychological situation of adults with congenital heart disease.

Authors:  Caroline Andonian; Jürgen Beckmann; Sabina Biber; Peter Ewert; Sebastian Freilinger; Harald Kaemmerer; Renate Oberhoffer; Lars Pieper; Rhoia Clara Neidenbach
Journal:  Cardiovasc Diagn Ther       Date:  2018-12

2.  Cardiac Arrhythmias in Adults With Congenital Heart Disease: Scope, Specific Problems, and Management.

Authors:  Ian Lindsay; Jeremy P Moore
Journal:  Curr Treat Options Cardiovasc Med       Date:  2015-12

3.  Posttraumatic stress and quality of life with the totally subcutaneous compared to conventional cardioverter-defibrillator systems.

Authors:  Julia Köbe; Katharina Hucklenbroich; Nils Geisendörfer; Markus Bettin; Gerrit Frommeyer; Florian Reinke; Dirk Dechering; Markus Burgmer; Lars Eckardt
Journal:  Clin Res Cardiol       Date:  2016-11-22       Impact factor: 5.460

4.  Age, Sex, and Remote Monitoring Differences in Device Acceptance for Patients With Implanted Cardioverter Defibrillators in Canada.

Authors:  Jessica Ng; Samuel F Sears; Derek V Exner; Lucy Reyes; Xenia Cravetchi; Peggy Cassidy; James Morton; Carmen Lohrenz; Aaron Low; Roopinder K Sandhu; Robert S Sheldon; Satish R Raj
Journal:  CJC Open       Date:  2020-06-16

Review 5.  Detection and discrimination of tachycardia in ICDs manufactured by St. Jude Medical.

Authors:  Jan Zdarek; Carsten W Israel
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2016-09-07

6.  Relation between detection rate and inappropriate shocks in single versus dual chamber cardioverter-defibrillator--an analysis from the OPTION trial.

Authors:  Christof Kolb; Marcio Sturmer; Dominique Babuty; Peter Sick; Jean Marc Davy; Giulio Molon; Jörg Otto Schwab; Giuseppe Mantovani; Andrew Wickliffe; Carsten Lennerz; Verena Semmler; Pierre-Henri Siot; Sebastian Reif
Journal:  Sci Rep       Date:  2016-02-19       Impact factor: 4.379

7.  Embodying a New Meaning of Being At Risk: Living With an Implantable Cardioverter Defibrillator for Arrhythmogenic Right Ventricular Cardiomyopathy.

Authors:  April Manuel; Fern Brunger
Journal:  Glob Qual Nurs Res       Date:  2016-10-24

8.  Anxiety and depression in inherited channelopathy patients with implantable cardioverter-defibrillators.

Authors:  Sajya M Singh; Brittney Murray; Crystal Tichnell; Rebecca McClellan; Cynthia A James; Andreas S Barth
Journal:  Heart Rhythm O2       Date:  2021-06-09

9.  Predicting Survival in Repaired Tetralogy of Fallot: A Lesion-Specific and Personalized Approach.

Authors:  Sarah Ghonim; Michael A Gatzoulis; Sabine Ernst; Wei Li; James C Moon; Gillian C Smith; Ee Ling Heng; Jennifer Keegan; Siew Yen Ho; Karen P McCarthy; Darryl F Shore; Anselm Uebing; Aleksander Kempny; Francisco Alpendurada; Gerhard P Diller; Konstantinos Dimopoulos; Dudley J Pennell; Sonya V Babu-Narayan
Journal:  JACC Cardiovasc Imaging       Date:  2021-10-13

10.  Patient-Reported Outcomes in a Multidisciplinary Electrophysiology-Psychology Ventricular Arrhythmia Clinic.

Authors:  Uday Sandhu; Andrew T Nguyen; John Dornblaser; Andrew Gray; Karen Paladino; Charles A Henrikson; Adrienne H Kovacs; Babak Nazer
Journal:  J Am Heart Assoc       Date:  2022-07-29       Impact factor: 6.106

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.